Share:
The Medicines Patent Pool and ViiV Healthcare released a press release providing updates on their partnership 10 years after the signing of the voluntary licensing agreements for dolutegravir.
Access the press release here.
Source : Medicines Patent Pool
Related HIV and Co-Infections News
-
Infectious Disease Advisor: Real-world data support switch to doravirine-based ART: HIV-1 control and QOL
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.